Synaptogenix, Inc.
SNPX
$2.50
$0.09023.74%
NASDAQ
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 54.30% | -8.24% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 60.23% | -14.00% | |||
| Operating Income | -60.23% | 14.00% | |||
| Income Before Tax | 3.40% | -350.95% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 3.40% | -350.95% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 3.40% | -350.95% | |||
| EBIT | -60.23% | 14.00% | |||
| EBITDA | -60.34% | 14.03% | |||
| EPS Basic | 9.07% | -286.90% | |||
| Normalized Basic EPS | 56.21% | -312.19% | |||
| EPS Diluted | 9.07% | -286.90% | |||
| Normalized Diluted EPS | 56.21% | -312.19% | |||
| Average Basic Shares Outstanding | 2.83% | 9.40% | |||
| Average Diluted Shares Outstanding | 2.83% | 9.40% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | 1.00% | -- | |||